This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Veru’s 8K filing here.
Veru Company Profile
Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Further Reading
- Five stocks we like better than Veru
- What Are Dividend Champions? How to Invest in the Champions
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- The 3 Best Retail Stocks to Shop for in August
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What is the Hang Seng index?
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
